Treatment of latent tuberculosis infection in HIV infected persons (Q24241052)

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB3

Isoniazid preventive therapy and risk for resistant tuberculosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB3

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2F14651858.CD000171.PUB3

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

12 December 2020

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Lessons learned from use of highly active antiretroviral therapy in Africa

1 reference

12 December 2020

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group]

1 reference

12 December 2020

Co-infection with HIV and TB: double trouble

1 reference

12 December 2020

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

12 December 2020

Isoniazid for preventing tuberculosis in non-HIV infected persons

1 reference

12 December 2020

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

1 reference

12 December 2020

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

1 reference

12 December 2020

Treatment of latent tuberculosis infection in HIV infected persons

1 reference

12 December 2020

Effect of tuberculosis preventive therapy on HIV disease progression and survival in HIV-infected adults

1 reference

12 December 2020

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

12 December 2020

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

1 reference

12 December 2020

Diagnosing tuberculosis in HIV-infected patients: challenges and future prospects

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

1 reference

12 December 2020

Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities

1 reference

12 December 2020

Randomized trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy

1 reference

12 December 2020

Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals.

1 reference

12 December 2020

Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

Tuberculin reactivity and the risk of tuberculosis: a review

1 reference

12 December 2020

Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study

1 reference

12 December 2020

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

1 reference

12 December 2020

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults

1 reference

12 December 2020

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

1 reference

12 December 2020

American Thoracic Society. Diagnostic standards and classification of tuberculosis

1 reference

12 December 2020

Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection

1 reference

12 December 2020

Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients

1 reference

12 December 2020

Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.

1 reference

12 December 2020

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

1 reference

12 December 2020

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

12 December 2020

Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.

1 reference

12 December 2020

Tuberculin testing to detect latent tuberculosis in developing countries

1 reference

12 December 2020

10.1002/14651858.CD000171.PUB3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

317336

317336

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference